Realizing that the correlation between malware and HPC traces does not establish causation, Boston University graduate students Boyou Zhou, Rasoul Jahanshahi and Anmol Gupta, under the supervision of Professors Manuel Egele and Ajay Joshi, evaluated works that propose this HPC-based methodology for malware detection.
A novel four-step process has been developed by researchers including Assistant Professor Tommaso Ranzani (ME) and Assistant Professor Sheila Russo (ME) to construct microfluidic origami for reconfigurable pneumatic/hydraulic (MORPH) systems. Their work, published in Advanced Materials, details the process and demonstrates its capabilities with the fabrication of a highly complex soft structure.
Researchers have come up with a tool that offers a means of control over engineered cells, and it comes from a seemingly unlikely source: the hepatitis C genome. In combination with a widely available antiviral medication, the new system offers a novel tool: a highly specific way to turn engineered cells on and off, with an existing, proven medication.
With the development of a DIY framework named eVOLVER, Assistant Professor Ahmad ‘Mo’ Khalil (BME) is hoping to disrupt a longstanding experimental compromise. The work has been published online and is scheduled to appear as the cover story of the July issue of Nature Biotechnology.
As a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with Johnson & Johnson Innovation LLC (JJI) aimed at preventing, intercepting, and curing lung cancer, the leading cause of cancer deaths worldwide. Spiral (SE) will lead the effort.